Christopher B. Primiano
2015
In 2015, Christopher B. Primiano earned a total compensation of $4.2M as Senior Vice President, Corporate Development, General Counsel and Secretary at Karyopharm Therapeutics, a 95% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $100,200 |
---|---|
Option Awards | $3,216,835 |
Salary | $333,631 |
Stock Awards | $537,300 |
Other | $10,980 |
Total | $4,198,946 |
Primiano received $3.2M in option awards, accounting for 77% of the total pay in 2015.
Primiano also received $100.2K in non-equity incentive plan, $333.6K in salary, $537.3K in stock awards and $11K in other compensation.
Rankings
In 2015, Christopher B. Primiano's compensation ranked 2,041st out of 13,638 executives tracked by ExecPay. In other words, Primiano earned more than 85.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,041 out of 13,638 | 85th |
Division Manufacturing | 726 out of 5,190 | 86th |
Major group Chemicals And Allied Products | 263 out of 1,854 | 86th |
Industry group Drugs | 206 out of 1,528 | 87th |
Industry Pharmaceutical Preparations | 164 out of 1,182 | 86th |
Source: SEC filing on April 29, 2016.
Primiano's colleagues
We found three more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2015.